Gilead Sciences Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2022 | $6.59B | $197.0M | $19.0M |
| Jun 2022 | $6.26B | $2.03B | $1.14B |
| Sep 2022 | $7.04B | $2.84B | $1.79B |
| Mar 2023 | $6.35B | $1.71B | $1.01B |
| Jun 2023 | $6.60B | $1.67B | $1.05B |
| Sep 2023 | $7.05B | $2.62B | $2.18B |
| Mar 2024 | $6.69B | $-4.32B | $-4.17B |
| Jun 2024 | $6.95B | $2.64B | $1.61B |
| Sep 2024 | $7.55B | $888.0M | $1.25B |
| Mar 2025 | $6.67B | $2.24B | $1.32B |
| Jun 2025 | $7.08B | $2.47B | $1.96B |
| Sep 2025 | $7.77B | $3.33B | $3.05B |
| Mar 2026 | $6.96B | $2.59B | $2.02B |
| Jun 2026 | $7.80B | $-10.39B | $-10.50B |